|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Current concepts on osteonecrosis of the femoral head显示文摘It is estimated that 20000 to 30000 new patients are diagnosed with osteonecrosis annually accounting for approximately 10% of the 250000 total hip arthroplasties done annually in the United States. Thelack of level 1 evidence in the literature makes it difficult to identify optimal treatment protocols to manage patients with pre-collapse avascular necrosis of the femoral head, and early intervention prior to collapse is critical to successful outcomes in joint preserving procedures. There have been a variety of traumatic and atraumatic factors that have been identified as risk factors for osteonecrosis, but the etiology and pathogenesis still remains unclear. Current osteonecrosis diagnosis is dependent upon plain anteroposterior and frog-leg lateral radiographs of the hip, followed by magnetic resonance imaging(MRI). Generally, the first radiographic changes seen by radiograph will be cystic and sclerotic changes in the femoral head. Although the diagnosis may be made by radiograph, plain radiographs are generally insufficient for early diagnosis, therefore MRI is considered the most accurate benchmark. Treatment options include pharmacologic agents such as bisphosphonates and statins, biophysical treatments, as well as joint-preserving and joint-replacing surgeries. the surgical treatment of osteonecrosis of the femoral head can be divided into two major branches: femoral head sparing procedures(FHSP) and femoral head replacement procedures(FHRP). In general, FHSP are indicated at pre-collapse stages with minimal symptoms whereas FHRP are preferred at post-collapse symptomatic stages. It is difficult to know whether any treatment modality changes the natural history of core decompression since the true natural history of core decompression has not been delineated. | Joaquin Moya-Angeler Arianna L Gianakos Jordan C Villa Amelia Ni Joseph M Lane | 2015 | World Journal of Orthopedics2015，6，8： | 94 |
| 2 | Deaeration and pasteurization effects on the orange juice aromatic fraction显示文摘 | JORDAN M J GOODNER K L LAENCINA J | 2003 | J Lebensm Wiss Technol2003，36，： | 1 |
| 3 | Deaeration andpasteurization effects on the orange juice aromatic fraction显示文摘 | JORDAN M J GOODNER K L LAENCINA J | 2003 | LWT-Food Science and Technology2003，36，4： | 1 |
| 4 | Measuring In- dividual differences in implicit cognition: the implicit asso- ciation test显示文摘 | Greenwald A G Jordan E M Schwartz L K | 1998 | Journal of Personality and Social psycholo- gy1998，74，： | 1 |
| 5 | Estradiol protects a- gainst hippocampal damage and impairments in fear conditioning re- suiting from transient global ischemia in mice 显示文摘 | Durham J L Jordan K A DeVos M J | 2012 | Brain research2012，，1443： | 1 |
| 6 | Charaeterization of the aromatic profile in aqueous essence and fruit juice of yellow passion fruit( Passiflora edulis Sims F Flavicarpa degner) by GE- MS and GC/O显示文摘 | Jordan M J Goodner K L Shaw P E | 2002 | J Agri Food Chem2002，50，： | 1 |
| 7 | Cancer stem cells显示文摘 | Jordan C T Guzman M L Noble M | 2006 | N Engl J Med2006，355，12： | 1 |
| 8 | Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction 显示文摘 | JAMES L JANUZZI JR MD SHAFIQ U REHMAN M D ASIM A MOHAMMED M D ANJU BHARDWAJ M D LINDA BARAJAS R N JUSTINE BARAJAS HAN-NA KIM M D MPH AARON L BAGGISH M D RORY B WEINER M D ANNABEL CHEN-TOURNOUX MD JANE E MARSHALL RDCS STEPHANIE A MOORE M D WILLIAM D CARLSON M D GREGORY D LEWIS M D JORDAN SHIN M D DOROTHY SULLIVAN ANP KIMBERLY PARKS D O THOMAS J WANG M D SHAWN A GREGORY M D SHANMUGAM UTHAMALINGAM M D MARC J SEMIGRAN M D | 2011 | J Am Coll Cardiol2011，58，18： | 1 |
| 9 | Microtubules as a target for anticancer drugs 显示文摘 | JORDAN M A WILSON L | 2004 | Nate Rev Cancer2004，4，4： | 1 |
| 10 | Convergence Results for the EM Approach to Mixtures of Experts Architectures 显示文摘 | JORDAN M XU L | 1996 | Neural Networks1996，8，9： | 1 |
| 11 | The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘 | International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M | 2010 | Science2010，330，6010： | 1 |
| 12 | Exploiting tractable substructures in intractable networks 显示文摘 | LAWRENCE K SAUL L JORDAN M | 1996 | Advances in Neural Information Processing Systems1996，8，： | 1 |
| 13 | Microtubules as a target for anti- cancer drugs显示文摘 | JORDAN M A WILSON L | 2004 | Nature Reviews Cancer2004，4，4： | 1 |
| 14 | EULAR evidence based recommendations for the management of hip osteoarthritis,report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)显示文摘 | Zhang W Doherty M Arden N Bannwarth B Bijlsma J Gunther KP Hauselmann H J Herrero-Beaumont G Jordan K Kaklamanis P Leeb B Lequesne M Lohmander S Mazieres B Martin-Mola E Pavelka K Pendleton A Punzi L Swoboda B Varatojo R Verbruggen G Zimmermann-Gorska Ⅰ D | | 0，，05： | 1 |
| 15 | Microtubules as a target for anticancer drugs显示文摘 | Jordan M A Wilson L | | 0，，4： | 1 |
| 16 | A Simulation Model of the Three - dimensional Architecture of the Maize Root System显示文摘 | Pages L Jordan M O Picard D | 1989 | Plant and Soil1989，，119： | 1 |
| 17 | A simulation model of the three-dimensional architecture of the maize root system显示文摘 | Pages L Jordan M O Picard D | 1989 | Plant and Soil1989，119，1： | 1 |
| 18 | The role of serotonin in reflex modula tion and locomotor rhythm production in the mammalian spinal cord 显示文摘 | Schmidt B J Jordan L M | 2000 | Brain Res Bu112000，53，56： | 1 |
| 19 | Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults显示文摘 | Jordan J L Foster N E Holden M A | 2010 | Cochrane Database Syst Rev2010，65，00： | 1 |
| 20 | Investigation of peptide involvement in T cell alloreeognition using recombinant HLA class I multimers 显示文摘 | Whitelegg A M Oosten L E Jordan S | 2005 | J Immunol2005，175，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员